FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3745426016 | Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3745427013 | Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3745428015 | Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3745475015 | Retinoic acid syndrome | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5987171000241117 | syndrome de différenciation dû à une chimiothérapie concomitante d'une leucémie promyélocytaire aigüe | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| 5987181000241115 | syndrome de différenciation dû à une chimiothérapie concomitante d'une LPA (leucémie promyélocytaire aigüe) | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| 5987191000241118 | syndrome de l'acide rétinoïque | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Is a | séquelle | false | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Is a | Disorder of immune function (disorder) | true | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Is a | Acute promyelocytic leukemia, FAB M3 | true | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Is a | Complication of procedure | false | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | After | The treatment of disease using chemical agents or drugs that are selectively toxic to the causative agent of the disease, such as a virus, bacterium, or other microorganism. | true | Inferred relationship | Some | 2 | |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Finding site | Bone marrow structure | true | Inferred relationship | Some | 1 | |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Due to | The treatment of disease using chemical agents or drugs that are selectively toxic to the causative agent of the disease, such as a virus, bacterium, or other microorganism. | true | Inferred relationship | Some | 3 | |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Associated morphology | Acute promyelocytic leukaemia with PML::RARA fusion | true | Inferred relationship | Some | 1 | |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Is a | Complication of chemotherapy (disorder) | true | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Pathological process (attribute) | Abnormal immune process (qualifier value) | false | Inferred relationship | Some | 4 | |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Is a | Disorder following clinical procedure | false | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Is a | Complication of introduction procedure | true | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Pathological process (attribute) | Abnormal immune process (qualifier value) | true | Inferred relationship | Some | 1 | |
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Is a | Hematologic complication of procedure | true | Inferred relationship | Some | ||
| Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder) | Is a | Neoplastic complication of procedure | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets